Sign In

Alain Mititelu

CEO at Neuro-Concepts Ltd/4 provisional IPs area of Neurodegenerative Diseases/Emeritus Scientist

Alain Mititelu is a scientist and doctor, specializing as a psychiatrist with over 25 years of experience in the pharmaceutical industry, including 10 years as a psychiatrist in the UK working for a public company, VirginCare.

He served as a Consultant Psychiatrist in Offender Mental Health in the Norwich Prison Cluster and other NHS units, showcasing a strong work ethic and perfectionist approach.

Alain has a notable background in CNS neuroscience psychiatry and neurology, with extensive expertise in various aspects of clinical research, including phase 1 to phase 3 trials, preclinical safety, pharmacovigilance, quality and risk management, and regulatory affairs submissions.

His experience encompasses research development, clinical project management, and overseeing clinical trials across all stages of product life cycles.

Alain's current focus is on a drug targeting Alzheimer's disease, with the market valued at $4.5 billion annually, promising significant financial rewards upon FDA approval.

The company he leads, Neuro-Concepts, is in the process of going public, offering an IPO to leverage its scientific and financial acumen for shareholders.

Under his leadership, the Leviathan project consolidates groundbreaking research in neurodegenerative diseases and cannabinoid-related studies.

Alain Mititelu
Add to my network

Location

Derby, England, United Kingdom